The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.

Clark, Joshua J; Secrest, Aaron M; Hull, Christopher M; Eliason, Mark J; Leiferman, Kristin M; Gleich, Gerald J; Powell, Douglas L

Clark, Joshua J; Secrest, Aaron M; Hull, Christopher M; Eliason, Mark J; Leiferman, Kristin M; Gleich, Gerald J; Powell, Douglas L.

Afiliação

Clark JJ; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Secrest AM; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Hull CM; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Eliason MJ; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Leiferman KM; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Gleich GJ; Department of Dermatology, University of Utah, Salt Lake City, Utah.
Powell DL; Department of Dermatology, University of Utah, Salt Lake City, Utah. Electronic address: douglas.powell@hsc.utah.edu.

J Am Acad Dermatol ; 74(6): 1274-6, 2016 Jun.

Article em En | MEDLINE | ID: mdl-27185439

Assuntos

Antialérgicos/administração & dosagem; Omalizumab/administração & dosagem; Urticária/tratamento farmacológico; Adulto; Doença Crônica; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos; Índice de Gravidade de Doença

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Antialérgicos / Omalizumab Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google